Global Glucosamine Industry

NEW YORK, Sept. 8, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Global Glucosamine Industry

http://www.reportlinker.com/p0611077/Global-Glucosamine-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Vitamin_a

This report analyzes the worldwide markets for Glucosamine in Metric Tons. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 148 companies including many key and niche players such as Alcan Chemical Division, Alfa Chem, Cargill, Inc., CMP Therapeutics Ltd., Dalian Lijian Bio-Technology Development Co., Ltd., Dalian Xindie Chitin Co., Ltd., Dee Pharmaceuticals Ltd., Ethical Naturals, Inc., FabriChem, Inc., Golden-Shell Biochemical Co., Ltd., Koyo Chemical Company Limited, Navamedic ASA, Nutraceutix, Inc., Nutramax Laboratories, Inc., NUTRILITE, Promax Nutrition Corporation, Schiff Nutrition International, Inc., Shandong DongYing Development Zone Marine Biochemical Co., Ltd., Shandong Jinan Haidebei Marine BioengineeringCo. Ltd., Simply Supplements, Synasia, Inc., Taizhou Candorly Sea Biochemical & Health Products Co., Ltd., Triarco Industries, Inc., Xiamen Blue Bay Science & Technology Co., Ltd., and Zhejiang Freeman Shinfuda Co. Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 3

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

2. MARKET OVERVIEW 4

Glucosamine: The Leading Dietary Supplement in the Joint

Health Market 4

Global Market Analysis 4

Market Trends 6

Nutritional Supplements Industry Remains Resilient to

Economic Downturn 6

Aging Population Drives Glucosamine Market 6

Table 1: Worldwide Distribution of 65+ Population by

Region/Country: As on July 2009 (includes corresponding

Graph/Chart) 6

China Races Ahead in Glucosamine Production and Supply Worldwide 7

Newer Formulations of Glucosamine Being Introduced 7

Glucosamine Fortification: An Emerging Trend 8

Table 2: Glucosamine Product Launches by Region (2006-2009):

Asia-Pacific, North America, and Europe (includes

corresponding Graph/Chart) 8

Plant-Derived Glucosamine Gains Popularity 9

Combination Supplements: A Double Whammy Success 9

Select Combination Supplements At a Glance 10

Functional Food and Beverages: Promising End-Market for

Glucosamine 10

Alternative Joint Health Ingredients May Have an Impact on

Future Sales 10

3. PRODUCT OVERVIEW 12

Glucosamine and the Benefits Offered 12

Why Glucosamine Supplements? 12

Chitin and Chitosan: A Prelude 12

Manufacturing of Glucosamine 13

Forms of Glucosamine 13

Glucosamine Sulfate Takes the Front Seat 13

Glucosamine Hydrochloride: Efficacy Still Doubted 14

Glucosamine and Recommended Dose 14

Glucosamine Interactions 14

Combo Power: Glucosamine Plus Other Ingredients 14

Diverse Views on Glucosamine/Chondroitin Use for

Osteoarthritis Treatment 14

CosaminDS Ranked No.1 15

Shifting Preferences Towards Glucosamine Plus MSM Supplement 15

Glucosamine and Omega-3 Fatty Acids: A New Combination 16

Select Glucosamine Supplements Available in the Market - A Review 16

Oral Glucosamine 16

Osteo Bi-Flex® (NBTY, Inc.) 16

Move Free® Advanced (Schiff Nutrition Group, Inc.) 16

Cosamin® DS (Nutramax Laboratories, Inc) 17

TripleFlex® (Pharmavite LLC) 17

Vegetarian Glucosamine 17

Regenasure® (Cargill) 17

Regenasure Applications by Select Country 18

JointAstin (Cyanotech) 18

Liquid Vegetarian Glucosamine/MSM (Trace Minerals Research) 18

Avoca® ASU (Nutramax Laboratories, Inc.) 18

GlucosaGreen (Hygieia Health) 18

GreenGrown glucosamine (Ethical Naturals, Inc.) 19

Liquid Glucosamine 19

Major Liquid Glucosamine Brands 19

Topical Glucosamine Still Inferior Over Other Formulations 19

Urah™ TGC: A Topical Glucosamine Brand 20

4. NEW RESEARCH FINDINGS ON GLUCOSAMINE 21

High Doses of Glucosamine Supplements Can Increase Diabetes Risk 21

Zero Adverse Affects of Oral Glucosamine on Glucose Metabolism 21

Glucosamine Fails to Relieve Lower Back Pain 21

Positive Affects of Glucosamine Sulfate and Omega-3 Combo on

Joint Health 21

Eggshell Membrane Outweighs Glucosamine for Joint Health Under

ESM Funded Clinical Trial 22

Prolonged Use of High Purity and Concentrated Chondroitin

Sulphate May Avoid Joint Degradation 22

InterHealth's Patented Collagen Ingredient Outperforms

Glucosamine and Chondroitin for Joint Health 22

Glucosamine to Treat UV- Related Skin Damage 23

Glucosamine Feared to Affect Fertility 23

5. PRODUCT INTRODUCTIONS AND LAUNCHES 24

Simply Supplements Launches Glucosamine Supplements for Bone

Health 24

OXIS Launches ErgoFlex™ Dietary Supplements 24

MonaVie Introduces MonaVie Active and MonaVie Original 24

Forum Health to Launch Glucosamine Hydrochloride Supplement 24

Nutramax Launches Start Cosamin® ASU Program 24

Schiff Nutrition Rolls Out Move Free® Advanced, the Next-

generation Joint Care Product 25

Nutrilite Unveils Glucosamine-7 for Better Joint Comfort in

Shorter Period 25

Promax Nutrition Launches Joint Xpress™ 26

Cargill and The Elations Company to Introduce the Elations®

Joint Health Supplement Beverages 26

Triarco Launches Liquid Glucosamine 26

Ethical Naturals Rolls Out GreenGrown Glucosamine 27

Planet Nutrition Introduces Planet Nutrition Supplements Range 27

Pharma Base Introduces Osamine™ Pharmaceutical Grade Glucosamine 27

Dr Organics Unveils Body Shot 27

Navamedic Launches Mobilat Glucosamin 27

Health Perception Launches GlucOsamax Extra 28

Herbalife Unveils a Series of Anti-Aging Products Containing

Glucosamine 28

Schiff Nutrition Launches New Move Free® Advanced 28

Reno Introduces New Liquid Dietary Supplement 28

Health Perception Launches ArheumaCare 28

Neptune Technologies Introduces Glucosamine/NKO™ 29

BR Pharmaceuticals Reintroduces Valupak 29

6. RECENT INDUSTRY ACTIVITY 30

Corwin Beverage to Distribute TandemRain's Sports Rejuvenation

Products 30

Dee Pharma Signs Exclusive Permanent Distribution Deal with

Laboratoires Expanscience 30

Thai Union and Nippon Suisan Joint Venture to Manufacture

Glucosamine 30

Camlin Fine Chemicals to Foray into the US and European Markets 30

Ethical Naturals and Cargill Reconciles Glucosamine Patent

Dispute 30

Koyo Chemical to Expand Product Portfolio 31

Bayer HealthCare Acquires OTC Business of Sagmel 31

Hygieia Receives EU Approval for GlucosaGreen, a Vegetarian

Glucosamine 31

Navamedic Inks Agreement with Queisser Pharma 32

Lescarden Receives First Poly-NAG Order from Pascual Laboratories 32

Navamedic Divests ChitiNor to Seagarden 32

Navamedic Enters into a Deal with William Ransom 32

Navamedic Signs Agreement with French Partner to Market Glucomed 33

7. FOCUS ON SELECT PLAYERS 34

Alcan Chemical Division (US) 34

Alfa Chem (US) 34

Cargill, Inc. (US) 34

CMP Therapeutics Ltd. (UK) 35

Dalian Lijian Bio-Technology Development Co., Ltd (China) 35

Dalian Xindie Chitin Co., Ltd. (China) 35

Dee Pharmaceuticals Ltd (UK) 35

Ethical Naturals, Inc. (US) 36

FabriChem, Inc. (US) 36

Golden-Shell Biochemical Co., Ltd. (China) 36

Koyo Chemical Company Limited (Japan) 36

Navamedic ASA (Norway) 37

Nutraceutix, Inc. (US) 37

Nutramax Laboratories, Inc. (US) 37

NUTRILITE (US) 37

Promax Nutrition Corporation (US) 38

Schiff Nutrition International, Inc. (US) 38

Shandong DongYing Development Zone Marine Biochemical Co.,

Ltd. (China) 39

Shandong Jinan Haidebei Marine Bioengineering Co. Ltd. (China) 39

Simply Supplements (UK) 39

Synasia, Inc. (US) 40

Taizhou Candorly Sea Biochemical & Health Products Co., Ltd.

(China) 40

Triarco Industries, Inc (USA) 40

Xiamen Blue Bay Science & Technology Co., Ltd (China) 41

Zhejiang Freeman Shinfuda Co. Ltd. (China) 41

8. GLOBAL MARKET PERSPECTIVE 42

Table 3: World Recent Past, Current & Future Analysis for

Glucosamine by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), and Rest of World Markets

Independently Analyzed with Annual Sales Figures in Metric

Tons for Years 2009 through 2017 (includes corresponding

Graph/Chart) 42

Table 4: World Historic Review for Glucosamine by Geographic

Region - US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), and Rest of World Markets Independently Analyzed with

Annual Sales Figures in Metric Tons for Years 2003 through

2008 (includes corresponding Graph/Chart) 43

Table 5: World 15-Year Perspective for Glucosamine by

Geographic Region - Percentage Breakdown of Volume Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and

Rest of World Markets for Years 2003, 2010 & 2017 (includes

corresponding Graph/Chart) 44

9. THE UNITED STATES 45

A.Market Analysis 45

Current and Future Analysis 45

Arthritis: A Major Cause of Disability Among Elderly 45

Glucosamine: A Good Fit for Joint Problems 45

Market Overview 46

Key Trends & Issues 46

Private Label Emerges as a Popular Choice Amid Recession 46

Glucosamine Containing Products Grow in Number 46

Product Introductions 47

Strategic Corporate Developments 50

Focus on Select Players 51

B.Market Analytics 56

Table 6: The US Recent Past, Current & Future Analysis for

Glucosamine - Annual Sales Figures in Metric Tons for Years

2009 through 2017 (includes corresponding Graph/Chart) 56

Table 7: The US Historic Review for Glucosamine - Annual

Sales Figures in Metric Tons for Years 2003 through 2008

(includes corresponding Graph/Chart) 56

10. CANADA 57

Market Analysis 57

Table 8: Canadian Recent Past, Current & Future Analysis for

Glucosamine - Annual Sales Figures in Metric Tons for Years

2009 through 2017 (includes corresponding Graph/Chart) 57

Table 9: Canadian Historic Review for Glucosamine - Annual

Sales Figures in Metric Tons for Years 2003 through 2008

(includes corresponding Graph/Chart) 57

11. JAPAN 58

A.Market Analysis 58

Strategic Corporate Development 58

Koyo Chemical Company Limited - A Key Player 58

B.Market Analytics 59

Table 10: Japanese Recent Past, Current & Future Analysis

for Glucosamine - Annual Sales Figures in Metric Tons for

Years 2009 through 2017 (includes corresponding Graph/Chart) 59

Table 11: Japanese Historic Review for Glucosamine - Annual

Sales Figures in Metric Tons for Years 2003 through 2008

(includes corresponding Graph/Chart) 59

12. EUROPE 60

A.Market Analysis 60

The United Kingdom: A High Growth Market for Vitamins,

Minerals and Supplements 60

Table 12: UK Market for Vitamins, Minerals, and Supplements

(2007): Percentage Market Share Breakdown for

Multivitamins, Fish Oils, Single Vitamins, Glucosamine,

Evening Primrose & starflower Oils, Minerals, and Others

(includes corresponding Graph/Chart) 60

Table 13: UK Life Expectancy by Gender (1950-2020)

(includes corresponding Graph/Chart) 61

Product Introductions 61

Strategic Corporate Developments 62

Focus on Select Players 63

B.Market Analytics 65

Table 14: European Recent Past, Current & Future Analysis

for Glucosamine by Geographic Region - France, Germany,

Italy, UK, Spain, Russia, and Rest of Europe Markets

Independently Analyzed with Annual Sales Figures in Metric

Tons for Years 2009 through 2017 (includes corresponding

Graph/Chart) 65

Table 15: European Historic Review for Glucosamine by

Geographic Region - France, Germany, Italy, UK, Spain,

Russia, and Rest of Europe Markets Independently Analyzed

with Annual Sales Figures in Metric Tons for Years 2003

through 2008 (includes corresponding Graph/Chart) 66

Table 16: European 15-Year Perspective for Glucosamine by

Geographic Region - Percentage Share Breakdown of Volume

Sales for France, Germany, Italy, UK, Spain, Russia, and

Rest of Europe Markets for Years 2003, 2010 and 2017

(includes corresponding Graph/Chart) 67

12a. FRANCE 68

Market Analysis 68

Table 17: French Recent Past, Current & Future Analysis for

Glucosamine - Annual Sales Figures in Metric Tons for Years

2009 through 2017 (includes corresponding Graph/Chart) 68

Table 18: French Historic Review for Glucosamine - Annual

Sales Figures in Metric Tons for Years 2003 through 2008

(includes corresponding Graph/Chart) 68

12b. GERMANY 69

Market Analysis 69

Table 19: German Recent Past, Current & Future Analysis for

Glucosamine - Annual Sales Figures in Metric Tons for Years

2009 through 2017 (includes corresponding Graph/Chart) 69

Table 20: German Historic Review for Glucosamine - Annual

Sales Figures in Metric Tons for Years 2003 through 2008

(includes corresponding Graph/Chart) 69

12c. ITALY 70

Market Analysis 70

Table 21: Italian Recent Past, Current & Future Analysis for

Glucosamine - Annual Sales Figures in Metric Tons for Years

2009 through 2017 (includes corresponding Graph/Chart) 70

Table 22: Italian Historic Review for Glucosamine - Annual

Sales Figures in Metric Tons for Years 2003 through 2008

(includes corresponding Graph/Chart) 70

12d. THE UNITED KINGDOM 71

Market Analysis 71

Table 23: The UK Recent Past, Current & Future Analysis for

Glucosamine - Annual Sales Figures in Metric Tons for Years

2009 through 2017 (includes corresponding Graph/Chart) 71

Table 24: The UK Historic Review for Glucosamine - Annual

Sales Figures in Metric Tons for Years 2003 through 2008

(includes corresponding Graph/Chart) 71

12e. SPAIN 72

Market Analysis 72

Table 25: Spanish Recent Past, Current & Future Analysis for

Glucosamine - Annual Sales Figures in Metric Tons for Years

2009 through 2017 (includes corresponding Graph/Chart) 72

Table 26: Spanish Historic Review for Glucosamine - Annual

Sales Figures in Metric Tons for Years 2003 through 2008

(includes corresponding Graph/Chart) 72

12f. RUSSIA 73

Market Analysis 73

Table 27: Russian Recent Past, Current & Future Analysis for

Glucosamine - Annual Sales Figures in Metric Tons for Years

2009 through 2017 (includes corresponding Graph/Chart) 73

Table 28: Russian Historic Review for Glucosamine - Annual

Sales Figures in Metric Tons for Years 2003 through 2008

(includes corresponding Graph/Chart) 73

12g. REST OF EUROPE 74

Market Analysis 74

Table 29: Rest of Europe Recent Past, Current & Future

Analysis for Glucosamine - Annual Sales Figures in Metric

Tons for Years 2009 through 2017 (includes corresponding

Graph/Chart) 74

Table 30: Rest of Europe Historic Review for Glucosamine -

Annual Sales Figures in Metric Tons for Years 2003 through

2008 (includes corresponding Graph/Chart) 74

13. ASIA-PACIFIC 75

A.Market Analysis 75

China - Poised to Become Major Glucosamine Consumer 75

Arthritis in Australia 75

Product Introductions 75

Focus on Select Players 76

B.Market Analytics 79

Table 31: Asia-Pacific Recent Past, Current & Future

Analysis for Glucosamine - Annual Sales Figures in Metric

Tons for Years 2009 through 2017 (includes corresponding

Graph/Chart) 79

Table 32: Asia-Pacific Historic Review for Glucosamine -

Annual Sales Figures in Metric Tons for Years 2003 through

2008 (includes corresponding Graph/Chart) 80

14. REST OF WORLD 81

Market Analysis 81

Table 33: Rest of the World Recent Past, Current & Future

Analysis for Glucosamine - Annual Sales Figures in Metric

Tons for Years 2009 through 2017 (includes corresponding

Graph/Chart) 81

Table 34: Rest of the World Historic Review for Glucosamine-

Annual Sales Figures in Metric Tons for Years 2003 through

2008 (includes corresponding Graph/Chart) 82

COMPETITIVE LANDSCAPE

Total Companies Profiled: 148 (including Divisions/Subsidiaries - 150)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 60

Canada 5

Japan 5

Europe 21

Germany 2

The United Kingdom 11

Italy 1

Spain 2

Rest of Europe 5

Asia-Pacific (Excluding Japan) 58

Africa 1

------------------------------------------

To order this report:

Vitamin and Supplement Industry: Global Glucosamine Industry

Vitamin and Supplement Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker